StreetInsider

• Log in to your account:

  
  Log in
• Signup
• Home
• EPS Insider
• Event Calendar
• Conferences
• Classic Site

Upgrade to SI Premium - Free Trial

INmune Bio (INMB)

INmune Bio Completes Commercial Manufacturing Milestone Supporting Planned Global Registration Filings for CORDStrom™ Platform July 20, 2026 7:00 AM - StreetInsider INmune Bio publishes preclinical study on XPro1595 and brain injury July 15, 2026 7:01 AM - StreetInsider INmune Bio’s XPro1595 Prevents Brain-Injury-Induced Alzheimer's Pathology, Memory Loss, and Pain in New Peer-Reviewed Preclinical Study July 15, 2026 7:00 AM - Globe NewsWire INmune Bio’s XPro1595 Prevents Brain-Injury-Induced Alzheimer's Pathology, Memory Loss, and Pain in New Peer-Reviewed Preclinical Study July 15, 2026 7:00 AM - StreetInsider INmune Bio to present Phase 2 imaging data for XPro at AAIC 2026 July 9, 2026 7:00 AM - StreetInsider INmune Bio to Present Positive Phase 2 Imaging Data for XPro in Early Alzheimer’s Disease at AAIC July 9, 2026 7:00 AM - StreetInsider Form 4 Inmune Bio, Inc. For: Jul 02 Filed by: Juda Scott July 7, 2026 7:02 AM - SEC Filing Form 4 Inmune Bio, Inc. For: Jul 02 Filed by: Lowdell Mark William July 7, 2026 7:01 AM - SEC Filing Form 4 Inmune Bio, Inc. For: Jul 02 Filed by: Moss David J July 7, 2026 7:00 AM - SEC Filing Form 8-K Inmune Bio, Inc. For: Jun 30 July 1, 2026 7:16 AM - SEC Filing INmune Bio files CORDStrom patent in U.S. after favorable PCT opinion July 1, 2026 7:02 AM - StreetInsider INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion July 1, 2026 7:00 AM - StreetInsider INmune Bio receives MHRA pediatric plan approval for Ebstrocel June 25, 2026 7:00 AM - StreetInsider INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™ June 25, 2026 7:00 AM - StreetInsider Form 8-K Inmune Bio, Inc. For: Jun 23 June 23, 2026 4:06 PM - SEC Filing INmune Bio gets MHRA alignment for 2026 UK drug application June 23, 2026 8:03 AM - StreetInsider INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB June 23, 2026 8:00 AM - StreetInsider Form 8-K Inmune Bio, Inc. For: Jun 16 June 17, 2026 4:01 PM - SEC Filing Form 8-K Inmune Bio, Inc. For: Jun 02 June 2, 2026 4:00 PM - SEC Filing INmune Bio reports positive MRI results in Alzheimer's trial June 2, 2026 8:01 AM - StreetInsider INmune Bio reports positive MRI results in Alzheimer's trial June 2, 2026 8:00 AM - StreetInsider INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial June 2, 2026 8:00 AM - Globe NewsWire INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial June 2, 2026 8:00 AM - StreetInsider INmune Bio publishes Phase 2 Alzheimer's trial results in peer-reviewed journal May 15, 2026 8:00 AM - StreetInsider INmune Bio publishes phase 2 alzheimer's trial results in peer journal May 15, 2026 8:00 AM - StreetInsider INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform May 15, 2026 8:00 AM - Globe NewsWire Form 8-K Inmune Bio, Inc. For: May 14 May 14, 2026 4:06 PM - SEC Filing INmune Bio receives FDA fast track designation for alzheimer's drug May 14, 2026 8:00 AM - StreetInsider INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease May 14, 2026 8:00 AM - StreetInsider INmune Bio receives FDA fast track designation for alzheimer's drug May 14, 2026 8:00 AM - StreetInsider INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease May 14, 2026 8:00 AM - Globe NewsWire INmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech Sector Navigates Strategic Inflection Point May 13, 2026 8:00 AM - StreetInsider INmune Bio, Inc. (INMB) Tops Q1 EPS by 7c May 7, 2026 5:13 PM - StreetInsider Form 10-Q Inmune Bio, Inc. For: Mar 31 May 7, 2026 4:20 PM - SEC Filing INmune Bio Inc. Announces First Quarter 2026 Results and Provides Business Update May 7, 2026 4:00 PM - StreetInsider Form 8-K Inmune Bio, Inc. For: Apr 29 May 5, 2026 4:31 PM - SEC Filing INmune Bio expands CORDStrom platform collaboration with Anthony Nolan May 5, 2026 4:00 PM - StreetInsider INmune Bio and Anthony Nolan Announce Strategic Expansion of CORDStrom™ MSC Platform Collaboration to Target RDEB, Oncology, and Inflammatory Diseases May 5, 2026 4:00 PM - Globe NewsWire Biotech Leaders Launch National Alliance to Define the Future of American Innovation May 5, 2026 7:00 AM - BizWire INmune Bio Inc. to Report First Quarter 2026 Financial Results and Provide Corporate Update on Thursday, May 7th April 30, 2026 8:00 AM - Globe NewsWire Full Article List